About Edip Gurol, MD
Dr. Edip Gurol is a stroke neurologist with particular expertise in the care of patients at high risk for ischemic (blockage type) strokes and hemorrhages. His NIH-funded research focuses on clarifying the mechanisms of brain small vessel diseases that increase the risk of both types of strokes. Dr. Gurol is an international expert in stroke prevention for patients with atrial fibrillation and high hemorrhagic risk.
| 1988 - 1994 | Medical School | Istanbul University Cerrahpasa Medical School |
| 1995 - 2002 | Internship, Residency, and Fellowship | Istanbul University, Istanbul Medical School Hospital Neurology, Stroke |
| 2003 - 2005 | Clinical Research | Massachusetts General Hospital Neurology, Clinical Trials Unit |
| 2005 - 2009 | Residency | University of Iowa Hospitals and Clinics Neurology |
| 2009 - 2010 2010 - | Fellowship Stroke Neurologist | Mass General Brigham / Massachusetts General / Brigham Women Stroke and Neurocritical care Massachusetts General Hospital Stroke Service |
Clinical Interests:
- Cerebral amyloid angiopathy (CAA)
- Intracerebral hemorrhage (brain bleeds)
- Ischemic stroke (brain infarcts)
- Stroke
- Stroke Prevention
Treats:
- Adult
Languages:
- French, Turkish
Locations
Mass General Vascular Center: Stroke Service
55 Fruit St.
7th Floor, Suite 720
Boston, MA 02114
Phone: 617-726-8459
Medical Education
- MD, Istanbul University School of Medicine
- Residency, Istanbul University School of Medicine
- Fellowship, Istanbul University School of Medicine
- Fellowship, Massachusetts General Hospital
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Structural and Functional Magnetic Resonance Imaging Predictors of Hemorrhage Recurrence and Disease Progression in Cerebral Amyloid Angiopathy
Molecular Mechanisms of Brain Injury in Patients with Age-Related Cerebral Small Vessel Diseases
Understanding embolic and hemorrhagic risk in patients with atrial fibrillation at risk of intracranial hemorrhage and determining the best management approaches (pharmacological vs nonpharmacological)
Publications
-
Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk
Stroke. 2017; Dec 4. pii: STROKEAHA.117.017081. doi: 10.1161/STROKEAHA.117.017081. [Epub ahead of print]
Molecular Neuroimaging in Vascular Cognitive Impairment
Stroke. 2016 Apr;47(4):1146-52
Management of intracerebral hemorrhage.
Curr Atheroscler Rep. 2008 Aug ; 10 (4): 324-31
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
Neurology. 2006 Jan 10; 66 (1): 23-9